唯亞威 VIAV 深 滬
已收盤 09-26 16:00:00 美东时间
12.21
-0.080
-0.65%
華盛通- 最 高12.28
- 今 開12.28
- 成交量 152.99万股
- 最 低 12.165
- 昨 收 12.29
- 總市值 27.23亿
- 52周最高 12.907
- 市盈率 靜 79.18
- 換手率 0.69%
- 52周最低 8.10
- 委 比 91.72%
- 總股本 2.23亿
- 歷史最高 18.14
- 量 比 0.55
- 振 幅 0.94%
- 歷史最低 3.78
- 每 手 1
- 風險率 0.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多VIAVI Expands ONE LabPro® ONE-1600 1.6Tb Testing and Validation Platform
The new ONE1600ER module combined with enhancements to the MAP-300 portfolio help customers meet AI-driven demands CHANDLER, Ariz., Sept. 25, 2025 /PRNewswire/ -- VIAVI Solutions Inc. (VIAVI...
09-25 18:30
VIAVI Launches New Handheld Testers To Speed Up Multi-Gig Fiber, WiFi 7, And DOCSIS Service Activation
VIAVI Solutions Inc. (VIAVI) (NASDAQ:VIAV) has expanded its family of rugged and reliable portable devices for last-mile fiber service turn-up and activation with two new all-in-one handheld testers for multi-gig
09-17 18:34
VIAVI Announces New Integration with CrowdStrike Falcon® Next-Gen SIEM
CHANDLER, Ariz., Sept. 10, 2025 /PRNewswire/ -- VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced a partnership with CrowdStrike to integrate the VIAVI Observer network observabili...
09-10 18:30
Viavi Solutions Announces $250M Convertible Notes Issuance
Viavi Solutions ( ($VIAV) ) has shared an update. On August 13, 2025, Viavi Sol...
08-14 19:29
Viavi Solutions Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Throughout the last three months, 4 analysts have evaluated Viavi Solutions (NA...
08-12 05:00
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
B. Riley Securities Maintains Neutral on Viavi Solutions, Raises Price Target to $12
B. Riley Securities analyst Dave Kang maintains Viavi Solutions (NASDAQ:VIAV) with a Neutral and raises the price target from $11 to $12.
08-08 21:01
Viavi Solutions Sees Q1 Adj EPS $0.13-$0.14 vs $0.11 Est; Sees Sales $290.000M-$298.000M vs $275.638M Est
Viavi Solutions (NASDAQ:VIAV) is looking for Q1 Adj EPS of $0.13-$0.14 vs $0.11 analyst estimate. sees sales of $290.000 million-$298.000 million vs $275.638 million analyst estimate.
08-08 04:19
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
